PROFUSA, INC. Marketable Securities, Unrealized Gain (Loss)
PROFUSA, INC. (PFSA) reported Marketable Securities, Unrealized Gain (Loss) of -$3.17 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-10-09.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2024-10-09
- PROFUSA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2023-03-31 was -$3.17K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month |
|---|---|
| 2023-03-31 | -$3.17K 10-Q · filed 2024-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |